71 related articles for article (PubMed ID: 8563733)
21. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
[TBL] [Abstract][Full Text] [Related]
22. An extensive screen of the HLA region reveals an independent association of HLA class I and class II with susceptibility for systemic lupus erythematosus.
Martens HA; Nolte IM; van der Steege G; Schipper M; Kallenberg CG; Te Meerman GJ; Bijl M
Scand J Rheumatol; 2009; 38(4):256-62. PubMed ID: 19255932
[TBL] [Abstract][Full Text] [Related]
23. Study of a functional polymorphism in the p53 gene in systemic lupus erythematosus: lack of replication in a Spanish population.
Sánchez E; Sabio JM; Callejas JL; de Ramón E; de Haro M; Jiménez-Alonso J; Ortego-Centeno N; Sánchez-Román J; González-Gay MA; López-Nevot MA; González-Escribano MF; Martín J
Lupus; 2006; 15(10):658-61. PubMed ID: 17120592
[TBL] [Abstract][Full Text] [Related]
24. Association of the tumor necrosis factor alpha gene polymorphism with susceptibility and clinical-immunological findings of systemic lupus erythematosus.
Azizah MR; Kuak SH; Ainol SS; Rahim MN; Normaznah Y; Norella K
Asian Pac J Allergy Immunol; 2004; 22(2-3):159-63. PubMed ID: 15565953
[TBL] [Abstract][Full Text] [Related]
25. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
Lee YH; Kim YR; Ji JD; Sohn J; Song GG
J Rheumatol; 2001 Sep; 28(9):2008-11. PubMed ID: 11550967
[TBL] [Abstract][Full Text] [Related]
26. Association of catalase gene polymorphisms with catalase activity and susceptibility to systemic lupus erythematosus in the Suez Canal area, Egypt.
Ghaly MS; Ghattas MH; Labib SM
Lupus; 2012 Oct; 21(11):1244-9. PubMed ID: 22736749
[TBL] [Abstract][Full Text] [Related]
27. [Polymorphism of Fc gamma RIIIA-158F/V gene and promoter region of IL-10 gene in systemic lupus erythematosus in Kazakhs].
Guseva IA; Omarbekova ZhE; Miakotkin VA
Ter Arkh; 2003; 75(5):36-41. PubMed ID: 12847896
[TBL] [Abstract][Full Text] [Related]
28. G/T polymorphism in the interleukin-2 exon 1 region among Han Chinese systemic lupus erythematosus patients in Taiwan.
Lin YJ; Wan L; Sheu JJ; Huang CM; Lin CW; Lan YC; Lai CH; Hung CH; Tsai Y; Tsai CH; Lin WY; Liu HP; Lin TH; Huang YM; Tsai FJ
Clin Immunol; 2008 Oct; 129(1):36-9. PubMed ID: 18650128
[TBL] [Abstract][Full Text] [Related]
29. Deficiency of IRE1 and PERK signal pathways in systemic lupus erythematosus.
Wang J; Cheng Q; Wang X; Zu B; Xu J; Xu Y; Zuo X; Shen Y; Wang J; Shen Y
Am J Med Sci; 2014 Dec; 348(6):465-73. PubMed ID: 25226532
[TBL] [Abstract][Full Text] [Related]
30. Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients.
Xu AP; Bai J; Lü J; Liang YY; Li JG; Lai DY; Wan X; Huang HH
Chin Med J (Engl); 2007 Dec; 120(23):2124-8. PubMed ID: 18167187
[TBL] [Abstract][Full Text] [Related]
31. HLA-DRB1*15 confers susceptibility to juvenile SLE but is not associated with disease presentation: an Egyptian Study.
Mosaad YM; Hammad A; Youssef HM; Elhanbly S
Immunol Invest; 2010 Jan; 39(3):235-44. PubMed ID: 20380521
[TBL] [Abstract][Full Text] [Related]
32. Integrated analyses of a major histocompatibility complex, methylation and transcribed ultra-conserved regions in systemic lupus erythematosus.
Lin H; Sui W; Tan Q; Chen J; Zhang Y; Ou M; Xue W; Li F; Cao C; Sun Y; Dai Y
Int J Mol Med; 2016 Jan; 37(1):139-48. PubMed ID: 26717903
[TBL] [Abstract][Full Text] [Related]
33. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
Bertsias GK; Nakou M; Choulaki C; Raptopoulou A; Papadimitraki E; Goulielmos G; Kritikos H; Sidiropoulos P; Tzardi M; Kardassis D; Mamalaki C; Boumpas DT
Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphisms of interleukin 6 and interleukin 10 in Egyptian patients with systemic lupus eythematosus.
Talaat RM; Alrefaey SA; Bassyouni IH; Ashour ME; Raouf AA
Lupus; 2016 Mar; 25(3):255-64. PubMed ID: 26568585
[TBL] [Abstract][Full Text] [Related]
35. Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population.
D'Alfonso S; Colombo G; Della Bella S; Scorza R; Momigliano-Richiardi P
Tissue Antigens; 1996 Jun; 47(6):551-5. PubMed ID: 8813745
[TBL] [Abstract][Full Text] [Related]
36. Association of +3179G/A insulin-like growth factor-1 receptor polymorphism and insulin-like growth factor-1 serum level with systemic lupus erythematosus.
Stanilova SA; Ivanova MG; Karakolev IA; Stoilov RM; Rashkov RK; Manolova IM
Lupus; 2013 Nov; 22(13):1388-93. PubMed ID: 23989734
[TBL] [Abstract][Full Text] [Related]
37. Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan.
Lo SF; Wan L; Lin HC; Huang CM; Tsai FJ
J Rheumatol; 2008 Nov; 35(11):2113-8. PubMed ID: 19004052
[TBL] [Abstract][Full Text] [Related]
38. Gm allogenotype distribution and lack of HLA-DR, Gm interaction in SLE and CREST/PSS.
Jazwinska EC; Dunckley H; Gatenby PA; Serjeantson SW
Immunol Cell Biol; 1989 Aug; 67 ( Pt 4)():261-5. PubMed ID: 2570039
[TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant.
Arnett FC; Olsen ML; Anderson KL; Reveille JD
J Clin Invest; 1991 May; 87(5):1490-5. PubMed ID: 1673688
[TBL] [Abstract][Full Text] [Related]
40. Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus.
Tjernström F; Hellmer G; Nived O; Truedsson L; Sturfelt G
Lupus; 1999; 8(2):103-8. PubMed ID: 10192503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
